Dr. Reddy's Laboratories has refuted media reports alleging a 25% reduction in workforce costs. The Hyderabad-based ...

Dr Rob Grundy has been appointed for a three-year term as the new northern co-chair of the US-Ireland R&D Partnership ...

VanEck Pharmaceutical ETF (PPH) offers stability and a high dividend yield. Read this article to know why I rate PPH ETF as a ...

Novartis plans to spend $23 billion over the next five years to expand its manufacturing, research and technology presence in the U.S.

Roche's strong U.S. presence and diversified product portfolio may mitigate the impact of potential tariffs, making it a ...

Novartis expects the new capacity will allow it to produce all of its key medicines “end to end” in the U.S., as the Trump ...

AI tools are faster at drafting clinical trial documents, but human writers remain indispensable for logical reasoning.

Swiss pharma group Novartis has said it will expand its US manufacturing and research and development with a $23bn investment over five years, as drugmakers reconfigure their supply chains as part of ...

On the heels of similar investment pledges from Eli Lilly and Johnson & Johnson, Switzerland’s Novartis is stepping up to the ...

The Inflation Reduction Act (IRA) is expected to profoundly influence the clinical development strategies of pharma companies ...

President Trump said his administration will soon impose tariffs on pharmaceuticals coming from foreign countries ...